DK1032376T3 - Anvendelse af benzhydrylsulfinylderivater til behandling af søvnighed af medicinal oprindelse - Google Patents
Anvendelse af benzhydrylsulfinylderivater til behandling af søvnighed af medicinal oprindelseInfo
- Publication number
- DK1032376T3 DK1032376T3 DK98955701T DK98955701T DK1032376T3 DK 1032376 T3 DK1032376 T3 DK 1032376T3 DK 98955701 T DK98955701 T DK 98955701T DK 98955701 T DK98955701 T DK 98955701T DK 1032376 T3 DK1032376 T3 DK 1032376T3
- Authority
- DK
- Denmark
- Prior art keywords
- treatment
- sleepiness
- derivatives
- benzhydrylsulfinyl
- medicinal origin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9714519A FR2771004B1 (fr) | 1997-11-19 | 1997-11-19 | Utilisation de derives de benzhydryl sulfinyle pour la fabrication de medicaments ayant un effet eveillant dans des situations de troubles de la vigilance d'origine medicamenteuse |
PCT/FR1998/002478 WO1999025329A1 (fr) | 1997-11-19 | 1998-11-19 | Utilisation de derives de benzhydryl sulfinyle pour traiter la somnolence d'origine medicamenteuse |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1032376T3 true DK1032376T3 (da) | 2002-08-26 |
Family
ID=9513542
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK98955701T DK1032376T3 (da) | 1997-11-19 | 1998-11-19 | Anvendelse af benzhydrylsulfinylderivater til behandling af søvnighed af medicinal oprindelse |
Country Status (10)
Country | Link |
---|---|
US (1) | US6566404B2 (da) |
EP (1) | EP1032376B1 (da) |
AT (1) | ATE216879T1 (da) |
AU (1) | AU743915B2 (da) |
CA (1) | CA2310141C (da) |
DE (1) | DE69805202T2 (da) |
DK (1) | DK1032376T3 (da) |
ES (1) | ES2177084T3 (da) |
FR (1) | FR2771004B1 (da) |
WO (1) | WO1999025329A1 (da) |
Families Citing this family (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6346548B1 (en) | 1999-08-16 | 2002-02-12 | Cephalon, Inc. | Compositions including modafinil for treatment of attention deficit hyperactivity disorder and multiple sclerosis fatigue |
US6455588B1 (en) | 1999-08-20 | 2002-09-24 | Cephalon, Inc. | Compositions including modafinil for treatment of eating disorders and for appetite stimulation |
FR2804322B1 (fr) * | 2000-01-31 | 2002-04-19 | Lafon Labor | Utilisation du modafinil pour la fabrication d'un medicament destine a corriger les troubles de la vigilance associes aux myopathies |
US6492396B2 (en) * | 2000-05-16 | 2002-12-10 | Cephalon, Inc. | Substituted thioacetamides |
US6670358B2 (en) * | 2000-05-16 | 2003-12-30 | Cephalon, Inc. | Substituted thioacetamides |
SK2242003A3 (en) * | 2000-07-27 | 2003-10-07 | Teva Pharma | Crystalline and pure modafinil, and process of preparing the same |
US6919378B2 (en) | 2000-10-11 | 2005-07-19 | Cephalon, Inc. | Pharmaceutical solutions of modafinil compounds |
PT1330244E (pt) * | 2000-10-11 | 2009-01-27 | Cephalon Inc | Composições compreendendo compostos de modafinil |
US6489363B2 (en) * | 2000-10-11 | 2002-12-03 | Cephalon, Inc. | Pharmaceutical solutions of modafinil compounds |
SK287126B6 (sk) * | 2000-10-11 | 2009-12-07 | Cephalon, Inc. | Kompozície obsahujúce modafinilové zlúčeniny, spôsob ich prípravy a ich použitie |
US6992219B2 (en) | 2002-08-09 | 2006-01-31 | Cephalon France | Modafinil polymorphic forms |
CA2518465A1 (en) | 2003-03-25 | 2004-10-14 | Takeda San Diego, Inc. | Dipeptidyl peptidase inhibitors |
AR045314A1 (es) * | 2003-05-13 | 2005-10-26 | Cephalon Inc | Composiciones farmaceuticas de analepticos y antidepresivos |
US20040242698A1 (en) * | 2003-05-13 | 2004-12-02 | Cephalon Inc. | Analeptic and antidepressant combinations |
AR045423A1 (es) * | 2003-05-13 | 2005-10-26 | Cephalon Inc | Combinaciones de analiticos y antidepresivos |
US20040229941A1 (en) * | 2003-05-13 | 2004-11-18 | Cephalon, Inc. | Analeptic and antidepressant combinations |
US20040229943A1 (en) * | 2003-05-16 | 2004-11-18 | Cephalon Inc | Analeptic and drug combinations |
US7723344B2 (en) * | 2003-08-13 | 2010-05-25 | Takeda San Diego, Inc. | Dipeptidyl peptidase inhibitors |
JP2007513058A (ja) * | 2003-09-08 | 2007-05-24 | 武田薬品工業株式会社 | ジペプチジルぺプチダーゼ阻害剤 |
EP1699777B1 (en) * | 2003-09-08 | 2012-12-12 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
US7368591B2 (en) | 2003-09-19 | 2008-05-06 | Cephalon France | Process for enantioselective synthesis of single enantiomers of modafinil by asymmetric oxidation |
GEP20094679B (en) * | 2004-03-15 | 2009-05-10 | Takeda Pharmaceuticals Co | Dipeptidyl peptidase inhibitors |
US7297817B2 (en) | 2004-04-13 | 2007-11-20 | Cephalon France | Thio-substituted arylmethanesulfinyl derivatives |
US7314875B2 (en) * | 2004-04-13 | 2008-01-01 | Cephalon, Inc. | Tricyclic aromatic and bis-phenyl sulfinyl derivatives |
EP1586560A1 (en) | 2004-04-13 | 2005-10-19 | Cephalon, Inc. | Thio-substituted arylmethanesulfinyl derivatives |
US7119214B2 (en) | 2004-04-13 | 2006-10-10 | Cephalon France | Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives |
US7449481B2 (en) * | 2004-04-13 | 2008-11-11 | Cephalon, Inc. | Thio-substituted biaryl-methanesulfinyl derivatives |
GEP20135838B (en) | 2005-09-14 | 2013-06-10 | Takeda Pharmaceutical | Dipeptidyl peptidase inhibitors usage at diabetes treatment |
EP1931350B2 (en) * | 2005-09-14 | 2021-08-04 | Takeda Pharmaceutical Company Limited | Administration of dipeptidyl peptidase inhibitors |
WO2007033265A1 (en) * | 2005-09-14 | 2007-03-22 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors for treating diabetis |
CA2622642C (en) * | 2005-09-16 | 2013-12-31 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
TW200745079A (en) * | 2005-09-16 | 2007-12-16 | Takeda Pharmaceuticals Co | Polymorphs of benzoate salt of 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-benzonitrile and methods of use therefor |
TW200745080A (en) * | 2005-09-16 | 2007-12-16 | Takeda Pharmaceuticals Co | Polymorphs of tartrate salt of 2-[2-(3-(R)-amino-piperidin-1-yl)-5-fluoro-6-oxo-6H-pyrimidin-1-ylmethyl]-benzonitrile and methods of use therefor |
WO2007112368A1 (en) * | 2006-03-28 | 2007-10-04 | Takeda Pharmaceutical Company Limited | Preparation of (r)-3-aminopiperidine dihydrochloride |
US20080317843A1 (en) * | 2006-07-12 | 2008-12-25 | Elan Corporation Plc | Nanoparticulate formulations of modafinil |
DK2073810T3 (da) * | 2006-09-13 | 2011-10-31 | Takeda Pharmaceutical | Anvendelse af 2-6-(3-aminio-piperidin-l-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-l-ylmethyl-4-fluor-benzonitril til behandling af diabetes, cancer, autoimmune sygdomme og HIV infektion |
US8324383B2 (en) | 2006-09-13 | 2012-12-04 | Takeda Pharmaceutical Company Limited | Methods of making polymorphs of benzoate salt of 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-benzonitrile |
TW200838536A (en) * | 2006-11-29 | 2008-10-01 | Takeda Pharmaceutical | Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use therefor |
US8093236B2 (en) | 2007-03-13 | 2012-01-10 | Takeda Pharmaceuticals Company Limited | Weekly administration of dipeptidyl peptidase inhibitors |
FR2987267B1 (fr) | 2012-02-28 | 2015-01-16 | Debregeas Et Associes Pharma | Application du modafinil dans le traitement de substitution des cacainomanes |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1584462A (en) * | 1977-03-31 | 1981-02-11 | Lafon Labor | N-diaryl-malonamide and diarylmethyl-sulphinyl-acetamide derivatives and pharmaceutical compositions containing them |
-
1997
- 1997-11-19 FR FR9714519A patent/FR2771004B1/fr not_active Expired - Fee Related
-
1998
- 1998-11-19 DK DK98955701T patent/DK1032376T3/da active
- 1998-11-19 US US09/554,682 patent/US6566404B2/en not_active Expired - Lifetime
- 1998-11-19 EP EP98955701A patent/EP1032376B1/fr not_active Expired - Lifetime
- 1998-11-19 AU AU12451/99A patent/AU743915B2/en not_active Ceased
- 1998-11-19 WO PCT/FR1998/002478 patent/WO1999025329A1/fr active IP Right Grant
- 1998-11-19 ES ES98955701T patent/ES2177084T3/es not_active Expired - Lifetime
- 1998-11-19 AT AT98955701T patent/ATE216879T1/de active
- 1998-11-19 CA CA2310141A patent/CA2310141C/fr not_active Expired - Fee Related
- 1998-11-19 DE DE69805202T patent/DE69805202T2/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
DE69805202T2 (de) | 2002-12-05 |
CA2310141C (fr) | 2010-04-27 |
WO1999025329A1 (fr) | 1999-05-27 |
US20030008925A1 (en) | 2003-01-09 |
AU1245199A (en) | 1999-06-07 |
ES2177084T3 (es) | 2002-12-01 |
CA2310141A1 (fr) | 1999-05-27 |
EP1032376A1 (fr) | 2000-09-06 |
FR2771004B1 (fr) | 2000-02-18 |
FR2771004A1 (fr) | 1999-05-21 |
DE69805202D1 (de) | 2002-06-06 |
AU743915B2 (en) | 2002-02-07 |
EP1032376B1 (fr) | 2002-05-02 |
US6566404B2 (en) | 2003-05-20 |
ATE216879T1 (de) | 2002-05-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1032376T3 (da) | Anvendelse af benzhydrylsulfinylderivater til behandling af søvnighed af medicinal oprindelse | |
ATE321529T1 (de) | Dosierungsform für eine verzögerte und zunehmende wirkstoffsfreisetzung | |
DE60121303D1 (de) | Mittel, wie nikotinamide oder cadpr zur behandlung von hautkrankheiten | |
NO20055173L (no) | Farmasoytisk kombinasjonsblanding omfattende modafinil og et annet legemiddel | |
CY1108401T1 (el) | Παραγωγα πυρρολοϊμιδαζολης, η παρασκευη τους, φαρμακευτικες συνθεσεις που τα περιεχουν και η χρηση τους ως νοοτροπικων παραγοντων | |
ATE212351T1 (de) | Androsten-derivate | |
ATE400258T1 (de) | Transdermales buprenorphin-dosierschema zwecks schmerzstillung | |
ATE243196T1 (de) | Piperidine und pyrrolidine | |
SE9802208D0 (sv) | Novel compounds | |
DK0595311T3 (da) | Kombinationspræparat af flupirtin og morphin til behandling af smerter og til forhindring af morphinafhængighed | |
ES2130152T3 (es) | Medicamentos para tratar dolencias inflamatorias o para analgesia que contienen un nsaid y ranitidina/citrato de bismuto. | |
SE9701161D0 (sv) | New use I | |
SE9802209D0 (sv) | Novel compounds | |
ATE247965T1 (de) | Paracetamol und buspiron enthaltende pharmazeutische zusammensetzung mit analgetischer wirkung | |
NO20032799D0 (no) | Nye terapeutiske anvendelser av tienylsykloheksylamin- derivater | |
DE60130253D1 (de) | Zusammensetzungen zur verhinderung der adhäsion | |
BR9710629A (pt) | Composi-Æo farmac-utica processo para sua prepara-Æo composto para utiliza-Æo como agente terap-utico e utiliza-Æo e utiliza-Æo de um composto | |
SE9802207D0 (sv) | Novel compounds | |
ITPD920102A1 (it) | Composizione farmaceutica utile per trattare malattie gastroenteriche, ferite e ustioni e come agente emostatico | |
UA34406A (uk) | Засіб для лікування розсіяного склерозу, спосіб лікування з його використанням та фармацевтична упаковка | |
UA31754A (uk) | Спосіб профілактики рецидивів меланоми шкіри | |
DK0859595T3 (da) | Terapeutisk præparat til transdermal indgivelse af aktive sfoffer gennem huden | |
FR2800276B1 (fr) | Composition et medicament, notamment anti-inflammatoire, constitue de ladite composition |